Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAME-AD: Terazosin in Alzheimer's Disease
NCT07796308Phase 2Not yet recruiting
- Start
- Aug 2027
- Primary completion
- Jul 2031
- Countries
- 1
01
Overview
A Phase 2 trial of terazosin in Alzheimer's disease (AD). Planned start Aug 2027; status: not yet recruiting.
02
Drugs
terazosin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07796308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07796308.